The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate
Open accessAbstract
Pharmacological ascorbate has been proposed as a potential anti-cancer agent when combined with radiation and chemotherapy. The anti-cancer effects of ascorbate are hypothesized to involve the autoxidation of ascorbate leading to increased steady-state levels of H 2 O 2; however, the mechanism(s) for cancer cell-selective toxicity remain unknown. The current study shows that alterations in cancer cell mitochondrial oxidative metabolism resulting in increased levels of O 2⋅- and H 2 O 2 are capable of disrupting intracellular iron metabolism, thereby selectively sensitizing non-small-cell lung cancer (NSCLC) and glioblastoma (GBM) cells to ascorbate through pro-oxidant chemistry involving redox-active labile iron and H 2 O 2. In addition, preclinical studies and clinical trials demonstrate the feasibility, selective toxicity, tolerability, and potential efficacy of pharmacological ascorbate in GBM and NSCLC therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an increased level of mitochondrial ROS in lung and glioblastoma cancer cells led to increased levels of intracellular labile iron through the upregulation of the Tf receptor (TfR), thus increasing the sensitivity of these cancer cells to ascorbate43.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [43]
In the citing paper
“Numerous preclinical and clinical studies indicate that parenteral injection of pharmacological ascorbate does not interfere with chemotherapy or radiotherapy and may even act synergistically43,104,105.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [43]
In the citing paper
“Numerous preclinical and clinical studies indicate that parenteral injection of pharmacological ascorbate does not interfere with chemotherapy or radiotherapy and may even act synergistically43,104,105.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [43]
In the citing paper
“This study shows that pharmacological ascorbate selectively sensitizes non-small-cell lung cancer (NSCLC) and glioblastoma (GBM) cells by generating redox-active labile iron and H2O2 using in vitro cell lines and mouse models.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [43]
In the citing paper
“In addition, it shows the potential efficacy of ascorbate therapy combined with other chemotherapies in patients with GBM and NSCLC.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761
[1] Role of free radicals and catalytic metal ions in human disease: An overview
Halliwell, B., & Gutteridge, J. M. C. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86093-b · Cited by 4,994
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., & Johnson, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011954 · Cited by 4,955
DISC ELECTROPHORESIS‐I BACKGROUND AND THEORY*
Ornstein, L. (1964) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1964.tb14207.x · Cited by 4,575
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
Chiller, J. O. H. S., Arrington, D. A. H., Elani, C. H. P. B., Anger, C., Andler, A. L. S., Rook, J. A. K., Hu, J., & Ohnson, D. A. H. J. (2002) · Cited by 3,730
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 2,504
Response criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621
Chen, Q., Espey, M. G., Krishna, M. C., Mitchell, J. B., Corpe, C. P., Buettner, G. R., Shacter, E., & Levine, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506390102 · Cited by 1,075
Self-citationVitamin C pharmacokinetics: Implications for oral and intravenous use
Padayatty, S. J., Sun, H., Wang, Y., Riordan, H. D., Hewitt, S. M., Katz, A., Wesley, R. A., & Levine, M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-7-200404060-00010 · Cited by 992
Design and Analysis of Phase I Clinical Trials
Storer, B. E. (1989) · Biometrics · doi:10.2307/2531693 · Cited by 939
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
Yun, J., Mullarky, E., Lu, C., Bosch, K. N., Kavalier, A., Rivera, K., Roper, J., Chio, I. I. C., Giannopoulou, E. G., Rago, C., et al. (2015) · Science · doi:10.1126/science.aaa5004 · Cited by 913
Catalytic Metals, Ascorbate and Free Radicals: Combinations to Avoid
Buettner, G. R., & Jurkiewicz, B. A. (1996) · Radiation Research · doi:10.2307/3579271 · Cited by 900
Self-citationChen, Q., Espey, M. G., Sun, A. Y., Pooput, C., Kirk, K. L., Krishna, M. C., Khosh, D. B., Drisko, J., & Levine, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804226105 · Cited by 854
Cameron, E., & Pauling, L. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.10.3685 · Cited by 710
Chen, Q., Espey, M. G., Sun, A. Y., Lee, J.-H., Krishna, M. C., Shacter, E., Choyke, P. L., Pooput, C., Kirk, K. L., Buettner, G. R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702854104 · Cited by 676
Self-citationAccelerated Titration Designs for Phase I Clinical Trials in Oncology
Simon, R. M., Rubinstein, L., Arbuck, S. G., Christian, M. C., Freidlin, B., & Collins, J. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.15.1138 · Cited by 641
Moertel, C. G., Fleming, T. R., Creagan, E. T., Rubin, J., O'Connell, M. J., & Ames, M. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120301 · Cited by 637
Creagan, E. T., Moertel, C. G., O'Fallon, J. R., Schutt, A. J., O'Connell, M. J., Rubin, J., & Frytak, S. (1979) · New England Journal of Medicine · doi:10.1056/nejm197909273011303 · Cited by 584
Dickinson, B. C., Huynh, C., & Chang, C. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1014103 · Cited by 520
Buettner, G. R. (1988) · Journal of Biochemical and Biophysical Methods · doi:10.1016/0165-022x(88)90100-5 · Cited by 510
Self-citationMa, Y., Chapman, J., Levine, M., Polireddy, K., Drisko, J., & Chen, Q. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007154 · Cited by 501
Glucose Transporter Isoforms GLUT1 and GLUT3 Transport Dehydroascorbic Acid
Rumsey, S. C., Kwon, O., Xu, G. W., Burant, C., Simpson, I. A., & Levine, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18982 · Cited by 481
Aykin‐Burns, N., Ahmad, I. M., Zhu, Y., Oberley, L. W., & Spitz, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20081258 · Cited by 433
Self-citationLow oxygen concentration extends the lifespan of cultured human diploid cells
Packer, L., & FUEHR, K. (1977) · Nature · doi:10.1038/267423a0 · Cited by 393
Fluorescence analysis of the labile iron pool of mammalian cells
Epsztejn, S., Kakhlon, O., Glickstein, H., Breuer, W., & Cabantchik, Z. I. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2126 · Cited by 391
Spitz, D. R., Sim, J. E., Ridnour, L. A., Galoforo, S., & Lee, Y. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06199.x · Cited by 333
Self-citationWelsh, J. L., Wagner, B. A., Erve, T. J. V. ‘., Zehr, P. S., Berg, D., Halfdanarson, T. R., Yee, N. S., Bodeker, K. L., Du, J., Roberts, L. J., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2070-8 · Cited by 318
Self-citationMechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer
Du, J., Martin, S. M., Levine, M., Wagner, B. A., Buettner, G. R., Wang, S.-H., Taghiyev, A. F., Du, C., Knudson, C. M., & Cullen, J. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1713 · Cited by 316
Self-citationDoskey, C. M., Buranasudja, V., Wagner, B. A., Wilkes, J. G., Du, J., Cullen, J. J., & Buettner, G. R. (2016) · Redox Biology · doi:10.1016/j.redox.2016.10.010 · Cited by 301
Self-citationA Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse
Liu, L., & Duff, K. (2008) · Journal of Visualized Experiments · doi:10.3791/960 · Cited by 294
Birch‐Machin, M. A., Briggs, H. L., Saborido, A. A., Bindoff, L. A., & Turnbull, D. M. (1994) · Biochemical Medicine and Metabolic Biology · doi:10.1006/bmmb.1994.1004 · Cited by 277
Monti, D., Mitchell, E. P., Bazzan, A. J., Littman, S. J., Zabrecky, G. P., Yeo, C. J., Pillai, M. V., Newberg, A. B., Deshmukh, S., & Levine, M. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029794 · Cited by 274
Liou, G.-Y., Döppler, H., DelGiorno, K. E., Zhang, L., Leitges, M., Crawford, H. C., Murphy, M. P., & Storz, P. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.029 · Cited by 270
Mitochondrial O2⋅¯ and H2O2 Mediate Glucose Deprivation-induced Stress in Human Cancer Cells
Ahmad, I. M., Aykin‐Burns, N., Sim, J. E., Walsh, S. A., Higashikubo, R., Buettner, G. R., Venkataraman, S., Mackey, M. A., Flanagan, S. W., Oberley, L. W., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411662200 · Cited by 246
Self-citationVerrax, J., & Calderón, P. B. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.016 · Cited by 235
Clement, M., Ramalingam, J. K., Long, L. H., & Halliwell, B. B. (2001) · Antioxidants and Redox Signaling · doi:10.1089/152308601750100687 · Cited by 231
Spitz, D. R., Dewey, W. C., & Li, G. C. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041310308 · Cited by 216
Self-citationCorazao-Rozas, P., Guerreschi, P., Jendoubi, M., André, F., Jonneaux, A., Scalbert, C., Garçon, G., Malet‐Martino, M., Balayssac, S., Rocchi, S., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1420 · Cited by 188
Sunaga, N., Shames, D. S., Girard, L., Peyton, M., Larsen, J. E., Imai, H., Soh, J., Sato, M., Yanagitani, N., Kaira, K., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0750 · Cited by 180
Ascorbate Autoxidation in the Presence of Iron and Copper Chelates
Buettner, G. R., & Czapski, G. (1986) · Free Radical Research Communications · doi:10.3109/10715768609051638 · Cited by 174
Self-citationPantopoulos, K., Mueller, S., Atzberger, A., Ansorge, W. J., Stremmel, W., & Hentze, M. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9802 · Cited by 163
Superoxide ion as a primary reductant in ascorbate-mediated ferretin iron release
Boyer, R. F., & McCleary, C. J. (1987) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(87)90017-7 · Cited by 156
Janmaat, M. L., Rodríguez, J. A., Gallegos-Ruiz, M. I., Kruyt, F. A. E., & Giaccone, G. (2005) · International Journal of Cancer · doi:10.1002/ijc.21290 · Cited by 149
Nath, K. A., Ngo, E. O., Hebbel, R. P., Croatt, A. J., Zhou, B., & Nutter, L. M. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.268.1.c227 · Cited by 139
Superoxide dismutase and superoxide radical in Morris hepatomas.
Bize, I., Oberley, L. W., & Morris, H. P. (1980) · PubMed · Cited by 138
Matsubara, D., Kishaba, Y., Ishikawa, S., Sakatani, T., Oguni, S., Tamura, T., Hoshino, H., Sugiyama, Y., Endo, S., Murakami, Y., et al. (2012) · Cancer Science · doi:10.1111/cas.12065 · Cited by 134
Zwacka, R. M., Dudus, L., Epperly, M. W., Greenberger, J. S., & Engelhardt, J. F. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.9-1381 · Cited by 127
Cell differentation, aging and cancer: The possible roles of superoxide and superoxide dismutases
Oberley, L. W., Oberley, T. D., & Buettner, G. R. (1980) · Medical Hypotheses · doi:10.1016/0306-9877(80)90123-1 · Cited by 127
Self-citationKukulj, S., Jaganjac, M., Boranić, M., Križanac, Š., Šantić, Ž., & Poljak‐Blaži, M. (2009) · Medical Oncology · doi:10.1007/s12032-009-9203-2 · Cited by 121
Modulation of Cellular Iron Metabolism by Hydrogen Peroxide
Caltagirone, A., Weiß, G., & Pantopoulos, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100245200 · Cited by 118
Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent
Riordan, N. H., Riordan, H. D., Meng, X., Li, Y., & Jackson, J. A. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90137-x · Cited by 116
Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer
Du, J., Cieslak, J. A., Welsh, J. L., Sibenaller, Z. A., Allen, B. G., Wagner, B. A., Kalen, A. L., Doskey, C. M., Strother, R. K., Button, A. M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1707 · Cited by 112
Self-citationCase, A. J., McGill, J. L., Tygrett, L. T., Shirasawa, T., Spitz, D. R., Waldschmidt, T. J., Legge, K. L., & Domann, F. E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.025 · Cited by 107
Self-citationA simple and sensitive assay for ascorbate using a plate reader
Vislisel, J. M., Schafer, F. Q., & Buettner, G. R. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.03.002 · Cited by 78
Self-citationRole of labile iron in the toxicity of pharmacological ascorbate
Du, J., Wagner, B. A., Buettner, G. R., & Cullen, J. J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.03.033 · Cited by 67
Self-citationCampbell, E. J., Vissers, M. C. M., Wohlrab, C., Hicks, K. O., Strother, R. M., Bozonet, S. M., Robinson, B. A., & Dachs, G. U. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.08.027 · Cited by 67
Extracellular iron diminishes anticancer effects of vitamin C: An in vitro study
Mojić, M., Pristov, J. B., Maksimović‐Ivanić, D., Jones, D. R., Stanić, M., Mijatović, S., & Spasojević, I. (2014) · Scientific Reports · doi:10.1038/srep05955 · Cited by 65
Moles of a Substance per Cell Is a Highly Informative Dosing Metric in Cell Culture
Doskey, C. M., Erve, T. J. V. ‘., Wagner, B. A., & Buettner, G. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132572 · Cited by 64
Self-citationASCORBIC ACID, CELL PROLIFERATION, AND CANCER
Cameron, E., & Rotman, D. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90215-2 · Cited by 62
Inhibitors of hydroperoxide metabolism enhance ascorbate-induced cytotoxicity
Olney, K., Du, J., Erve, T. J. V. ‘., Witmer, J. R., Sibenaller, Z. A., Wagner, B. A., Buettner, G. R., & Cullen, J. J. (2012) · Free Radical Research · doi:10.3109/10715762.2012.755263 · Cited by 59
Self-citationPharmacokinetic modeling of ascorbate diffusion through normal and tumor tissue
Kuiper, C., Vissers, M. C. M., & Hicks, K. O. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.09.023 · Cited by 45
Ibrahim, W. H., Habib, H. M., Kamal, H., Clair, D. K. S., & Chow, C. K. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.026 · Cited by 44
Measurement of Mn SOD and Cu Zn SOD Activity in Mammalian Tissue Homogenates
Spitz, D. R., & Oberley, L. W. (2001) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx0705s08 · Cited by 43
Self-citationPharmacological ascorbate and ionizing radiation (IR) increase labile iron in pancreatic cancer
Moser, J. C., Rawal, M., Wagner, B. A., Du, J., Cullen, J. J., & Buettner, G. R. (2013) · Redox Biology · doi:10.1016/j.redox.2013.11.005 · Cited by 41
Self-citationAhmad, I. M., Abdalla, M. Y., Aykin‐Burns, N., Simons, A. L., Oberley, L. W., Domann, F. E., & Spitz, D. R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.11.007 · Cited by 37
Self-citationDirect spectrophotometric measurement of supra-physiological levels of ascorbate in plasma
Witmer, J. R., Wetherell, B. J., Wagner, B. A., Du, J., Cullen, J. J., & Buettner, G. R. (2016) · Redox Biology · doi:10.1016/j.redox.2016.02.004 · Cited by 37
Self-citationSOD2 targeted gene editing by CRISPR/Cas9 yields Human cells devoid of MnSOD
Cramer-Morales, K. L., Heer, C. D., Mapuskar, K. A., & Domann, F. E. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.07.017 · Cited by 36
Self-citationSpringer, E. (1980) · PubMed · Cited by 33
Mutational analysis of the BRAF gene in human tumor cells
Ueda, M., Eisaku, T. O. J. I., Nunobiki, O., Izuma, S., Okamoto, Y., Torii, K., & Noda, S. (2008) · Human Cell · doi:10.1111/j.1749-0774.2008.00046.x · Cited by 22
Flagged first, then by citations
Research works printed but not linked: 1
- Spitz, 2001, Measurement of MnSOD and CuZnSOD activity in mammalian tissue homogenates, Curr. Protoc. Toxicol., Chapter 7
Cited by
Sorted by citations
Jomova, K., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03696-4 · Cited by 1,445
The Complex Interplay between Antioxidants and ROS in Cancer
Harris, I. S., & DeNicola, G. M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.03.002 · Cited by 659
Dixon, S. J., & Stockwell, B. R. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055844 · Cited by 607
Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases
Nakamura, T., Naguro, I., & Ichijo, H. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.06.010 · Cited by 529
Two Faces of Vitamin C—Antioxidative and Pro-Oxidative Agent
Kaźmierczak-Barańska, J., Boguszewska, K., Adamus-Grabicka, A., & Karwowski, B. T. (2020) · Nutrients · doi:10.3390/nu12051501 · Cited by 455
Metadata
- Authors
- Schoenfeld, J. D., Sibenaller, Z. A., Mapuskar, K. A., Wagner, B. A., Cramer-Morales, K. L., Furqan, M., Sandhu, S., Carlisle, T. L., Smith, M. C., Abu Hejleh, T., Berg, D. J., Zhang, J., Keech, J., Parekh, K. R., Bhatia, S., Monga, V., Bodeker, K. L., Ahmann, L., Vollstedt, S., Brown, H., Shanahan Kauffman, E. P., Schall, M. E., Hohl, R. J., Clamon, G. H., Greenlee, J. D., Howard, M. A., Schultz, M. K., Smith, B. J., Riley, D. P., Domann, F. E., Cullen, J. J., Buettner, G. R., Buatti, J. M., Spitz, D. R., & Allen, B. G.
- Affiliations
- University of Iowa (US)
- Galera Therapeutics, Inc. (United States) (US)
- Corresponding author
- Spitz, Douglas R.
- Allen, Bryan G.
- ORCID
- Schoenfeld, Joshua D.
- Sibenaller, Zita A.
- Mapuskar, Kranti A.
- Wagner, Brett A.
- Furqan, Muhammad
- Sandhu, Sonia
- Smith, Mark C.
- Berg, Daniel J.
- Zhang, Jun
- Keech, John
- Parekh, Kalpaj R.
- Monga, Varun
- Bodeker, Kellie L.
- Vollstedt, Sandy
- Brown, Heather
- Greenlee, Jeremy D.
- Howard, Matthew A.
- Schultz, Michael K.
- Riley, Dennis P.
- Domann, Frederick E.
- Cullen, Joseph J.
- Buettner, Garry R.
- Buatti, John M.
- Spitz, Douglas R.
- Allen, Bryan G.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 31
- Issue
- 4
- Pages
- 487-500.e8
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC5497844
- OpenAlex
- W2597494578
- Cited by
- 443
- References
- 74
- Citations by year
- 2026: 27 · 2025: 34 · 2024: 44 · 2023: 52 · 2022: 59 · 2021: 56 · 2020: 61 · 2019: 45 · 2018: 45 · 2017: 20
- FWCI
- 38.88
- Type
- journal article
- Language
- en
- Update notices
- erratum (2017-08-14)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Society for Radiation Oncology (JF2014-1)
- Carver Research Program of Excellence in Redox Biology
- US NIH (R01-CA182804, R01-CA184051, R01-CA169046, U01-CA166800)
- IBM
- CCSG (P30-CA086862)
- University of Iowa Medical Scientist Training Program (T32-GM007337, T32-CA078586)
- Galera Therapeutics
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- pharmacological ascorbate, reactive oxygen species, superoxide, hydrogen peroxide, mitochondrial oxidative metabolism, non-small cell lung cancer, glioblastoma
- MeSH terms
- Animals, Antineoplastic Combined Chemotherapy Protocols, Ascorbic Acid, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Female, Glioblastoma, Humans, Hydrogen Peroxide, Iron, Lung Neoplasms, Male, Mice, Nude, Oxygen, Radiation-Sensitizing Agents, Xenograft Model Antitumor Assays, Cell Line, Tumor, Chemoradiotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
